Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06281496
NA
AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor: Rigshospitalet, Denmark
View on ClinicalTrials.gov
Summary
A developed multimodal intervention targeting late effects in survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) will be evaluated in a two-arm randomized controlled trial with an internal pilot phase.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-11-01
Completion Date
2027-12-01
Last Updated
2025-08-01
Healthy Volunteers
No
Conditions
Interventions
BEHAVIORAL
AlloCare
Survivorship supportive care
Locations (1)
Rigshospitalet
Copenhagen, Denmark